Viewing Study NCT00526292


Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2026-03-01 @ 9:58 AM
Study NCT ID: NCT00526292
Status: COMPLETED
Last Update Posted: 2016-02-12
First Post: 2007-09-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 07-035
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View